Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Oct-Dec;10(4):462-5.
doi: 10.1590/s1679-45082012000400012.

Vaginal hysterectomy in non-prolapsed uteri: a 6-year experience

[Article in English, Portuguese]
Affiliations
Free article

Vaginal hysterectomy in non-prolapsed uteri: a 6-year experience

[Article in English, Portuguese]
Thomaz Rafael Gollop et al. Einstein (Sao Paulo). 2012 Oct-Dec.
Free article

Abstract

Objective: To evaluate the applicability of the technique of vaginal hysterectomy in non-prolapsed uterus.

Methods: A retrospective cohort study with 220 patients submitted to vaginal hysterectomy from January 2004 to July 2010 by the Vaginal Surgery and Pelvic Floor Team. Patients mean age was 44.4 years and they had on average three births (0-10 deliveries). The surgery was performed even in cases of previous abdominal surgery, and cesarean section was prevalent in 54.6% of patients.

Results: The mean uterus weight was 278.9 g. The mean operative time was 93 minutes, and length of hospital stay was 24 hours after surgery in 65% of cases. There were no cases of visceral injury. The mean postoperative complication was cellulitis of the vaginal vault that occurred in 11 cases (5%) that received antibiotics. Mean blood loss corresponded to 1.4 g/dL hemoglobin. From the analyzed sample, vaginal hysterectomy by vaginal route was feasible in 96.8% of patients, and abdominal conversion was necessary in 3.2%.

Conclusion: Vaginal hysterectomy is a minimally invasive surgery, with fewer complications, and low morbidity. We believe that this procedure should be indicated to treat gynecological benign diseases.

PubMed Disclaimer

Similar articles

LinkOut - more resources